Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to $91000.0.

  • Ocugen's Capital Expenditures fell 8205.13% to $91000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $163000.0, marking a year-over-year decrease of 9732.52%. This contributed to the annual value of $3.4 million for FY2024, which is 6768.8% down from last year.
  • Latest data reveals that Ocugen reported Capital Expenditures of $91000.0 as of Q3 2025, which was down 8205.13% from $43000.0 recorded in Q2 2025.
  • Ocugen's Capital Expenditures' 5-year high stood at $3.4 million during Q3 2023, with a 5-year trough of $13000.0 in Q4 2024.
  • Moreover, its 5-year median value for Capital Expenditures was $513000.0 (2024), whereas its average is $1.0 million.
  • As far as peak fluctuations go, Ocugen's Capital Expenditures skyrocketed by 148421.05% in 2021, and later plummeted by 9952.24% in 2024.
  • Over the past 5 years, Ocugen's Capital Expenditures (Quarter) stood at $192000.0 in 2021, then surged by 954.17% to $2.0 million in 2022, then skyrocketed by 34.49% to $2.7 million in 2023, then plummeted by 99.52% to $13000.0 in 2024, then surged by 600.0% to $91000.0 in 2025.
  • Its last three reported values are $91000.0 in Q3 2025, $43000.0 for Q2 2025, and $16000.0 during Q1 2025.